Stock LGST SEMR PARA
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News SEMR PARA

Equities

LGST

KYG8028L1077

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Semper Paratus Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
SEMR PARA : Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments - Form 8-K
PU
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN
AQ
Semper Paratus Acquisition Corporation(NasdaqGM:LGST) dropped from NASDAQ Composite Index
CI
Tevogen Bio Inc completed the acquisition of Semper Paratus Acquisition Corporation from a group of shareholders in a reverse merger transaction.
CI
Semper Paratus Acquisition Shareholders Approve Tevogen Bio Deal
MT
Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio
AQ
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq
AQ
Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination
AQ
Semper Paratus Acquisition : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
Semper Paratus Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Semper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing Requirement
AQ
Semper Paratus Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Semper Paratus Acquisition to Merge With Tevogen Bio; to Bring Tevogen Public
MT
Biotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listing
RE
Biotech firm Tevogen Bio to go public in $1.2 billion SPAC deal
RE
Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation
AQ
Tevogen Bio Inc entered into a merger agreement to acquire Semper Paratus Acquisition Corporation for $1.5 billion in a reverse merger transaction.
CI
Insider Sell: Semper Paratus Acquisition
MT
SEMPER PARATUS ACQUISITION CORP : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LGST Stock
  4. News SEMR PARA